| 000 | 01649cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030326.0 | ||
| 008 | 101221s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.19.04.M.Sc.2010.Na.D | ||
| 100 | 0 | _aNahla Ahmed Elgohary | |
| 245 | 1 | 0 |
_aDHCR24 relation to hepatocelluar carcinoma / _cNahla Ahmed Elgohary ; Supervised Heba Mohamed Elzawahry , Kyoko Tsukiyama - Kohara |
| 246 | 1 | 5 | _aعلاقة دى اتش سى أر 24 مع أورام الكبد الخبيثة |
| 260 |
_aCairo : _bNahla Ahmed Elgohary , _c2010 |
||
| 300 |
_a125P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medical | ||
| 520 | _aHepatocelluar carcinoma is one of the most lethal forms of cancer in the world . So early detection and treatment with the use of tumor markers is very important to improve the patient's outcome . The presence of DHCR24 in hepatocytes indicated tumorigenicity . A monoclonal antibody on a genome - wide scale against an HCV - expressing human hepatoblastoma - derived cell lin was generated ( DHCR24 monoclonal antibody ) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDHCR24 | |
| 653 | 4 | _aEarly diagnosis of hepatocelluar carcinoma | |
| 653 | 4 | _aHepatocelluar carcinoma | |
| 700 | 0 |
_aHeba Mohamed Elzawahry , _eSupervisor |
|
| 700 | 0 |
_aKyoko Tsukiyama - Kohara , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c32335 _d32335 |
||